Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.7.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
GS.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XWORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XWORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
XWNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XWNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.10ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
BA.1.10ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
BA.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.8ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
JN.8ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
JN.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KG.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
KG.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
KG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KG.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDJORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XDJORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
XDJNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDJNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.3.8ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
HK.3.8ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
HK.3.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.7ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
GK.1.7ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
GK.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.5.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
JN.5.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
JN.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.36.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
JN.1.36.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
JN.1.36.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.36.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.36.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86.4ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used